H Menzel
Impact in
-
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
-
- CAR-T cell therapy research
Papers in
- Oncology 6
- CAR-T cell therapy research 3
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- S. Thierfelder (3 shared papers)Horst Lindhofer (4 shared papers)W. Günther (1 shared paper)Lothar Hültner (1 shared paper)Andreas Umgelter (1 shared paper)Ralph Mocikat (2 shared papers)Dieter Hoffmann (1 shared paper)Martin Hutzenthaler (1 shared paper)
- Journals
- Cancer Gene Therapy (1 paper)Journal of Clinical Oncology (1 paper)Transfusion (1 paper)Anti-Cancer Drugs (1 paper)Gene Therapy (1 paper)
- Partner nations
- GermanySwitzerlandBelgium
In The Last Decade
H Menzel
11 papers receiving 108 citations
Peers
Comparison fields: 5 of 33
- Immunology 39
- Oncology 42
- Radiology, Nuclear Medicine and Imaging 27
- Infectious Diseases 21
- Animal Science and Zoology 10
Countries citing papers authored by H Menzel
This map shows the geographic impact of H Menzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Menzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Menzel more than expected).
Fields of papers citing papers by H Menzel
This network shows the impact of papers produced by H Menzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Menzel. The network helps show where H Menzel may publish in the future.
Co-authors
The 25 scholars most cited alongside H Menzel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 23 | |
| 2 | 1996 | 22 | |
| 3 | Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study. | 2005 | 15 |
| 4 | 1999 | 12 | |
| 5 | 2000 | 11 | |
| 6 | 2005 | 9 | |
| 7 | Antigenicity of low concentrated HDCS vaccine with and without adjuvant as compared to the standard fluid formulation. | 1978 | 7 |
| 8 | 2008 | 7 | |
| 9 | 2022 | 5 | |
| 10 | 2015 | 3 | |
| 11 | 2005 | 2 |
About H Menzel
H Menzel is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology, Infectious Diseases and Surgery, having authored 11 papers that have together received 116 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (4 papers), CAR-T cell therapy research (3 papers), Immunotherapy and Immune Responses (2 papers), Immune Cell Function and Interaction (2 papers), Acute Myeloid Leukemia Research (1 paper), Intraperitoneal and Appendiceal Malignancies (1 paper), Protein purification and stability (1 paper) and Hepatitis Viruses Studies and Epidemiology (1 paper). The work is most often cited by research in Immunology (39 citations), Oncology (42 citations), Radiology, Nuclear Medicine and Imaging (27 citations), Infectious Diseases (21 citations) and Animal Science and Zoology (10 citations). H Menzel has collaborated with scholars based in Germany, Switzerland and Belgium. Frequent co-authors include S. Thierfelder, Horst Lindhofer, W. Günther, Lothar Hültner, Andreas Umgelter, Ralph Mocikat, Dieter Hoffmann, Martin Hutzenthaler, Ulrike Protzer and Marcus Panning. Their work appears in journals such as Cancer Gene Therapy, Journal of Clinical Oncology, Transfusion, Anti-Cancer Drugs and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.